CalciMedica CALC
NASDAQ CALC
$1.65 +0.03 (+1.85%)
As of: Oct 1, 2026 · 3:55 PM EDT

CalciMedica (CALC) Liabilities and Shareholders Equity (2019 - 2026)

Updated

CalciMedica (CALC) posted Liabilities and Shareholders Equity of $19.5 million for Q2 2026, up 2.2% from $19.08 million a year earlier and up 126.5% from the prior quarter.

Analysis

CalciMedica (CALC) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, CalciMedica's Liabilities and Shareholders Equity came in at $13.59 million, down 31.3% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -33.1% (FY2020 to FY2025).
  • In prior years, CalciMedica's Liabilities and Shareholders Equity was $19.79 million in FY2024 (+62.4%), $12.19 million in FY2023 (+263.8%), $3.35 million in FY2022 (-95.2%) and $69.09 million in FY2021 (-32.1%).
  • The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity since Q1 2025.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in three of the last eight quarters, with an average decline of 6.8%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2023, with growth of 263.8%; the weakest was Q4 2022, with a decline of 95.2%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $8.61 million (Q1 2026), $13.59 million (Q4 2025) and $14.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 CalciMedica 5.54 Mn -13.06 Mn - 19.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.50 Mn
Mar 31, 2026 8.61 Mn
Dec 31, 2025 13.59 Mn
Sep 30, 2025 14.91 Mn
Jun 30, 2025 19.08 Mn
Mar 31, 2025 25.35 Mn
Dec 31, 2024 19.79 Mn
Sep 30, 2024 16.21 Mn
Jun 30, 2024 21.05 Mn
Mar 31, 2024 27.13 Mn
Dec 31, 2023 12.19 Mn
Sep 30, 2023 15.85 Mn
Jun 30, 2023 20.25 Mn
Mar 31, 2023 34.67 Mn
Dec 31, 2022 3.35 Mn
Sep 30, 2022 45.36 Mn
Jun 30, 2022 54.02 Mn
Mar 31, 2022 60.59 Mn
Dec 31, 2021 69.09 Mn
Sep 30, 2021 76.64 Mn
API Access

CalciMedica Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CALC&period=max&api_key=YOUR_API_KEY